Sort
59,101 grants matching “hypertension”
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
$1,533,089Kathleen E. Rodgers · University Of Arizona · U01 · FY2020 · AG
Clonal hematopoiesis in humans: determinants of development and progression
$1,532,120Christie M Ballantyne · Baylor College Of Medicine · R01 · FY2019 · HL
Mass Spectrometry Identification
$1,531,842Jason Williams · National Institute Of Environmental Health Sciences · ZIC · FY2025 · ES
Functional GWAS for LVH using iPS-derived Cardiomyocytes: The HyperGEN ciPS Stud
$1,531,660Ulrich Broeckel · Medical College Of Wisconsin · U01 · FY2013 · HL
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
$1,531,012Kathleen E. Rodgers · University Of Arizona · U01 · FY2021 · AG
Genetics and Epigenetics of Cardiovascular Disease
$1,530,994Tiffany Powell-Wiley · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL
Advancing Craniosynostosis Treatment (ACT)Rare Diseases Consortium
$1,530,000Eric Chien-Wei Liao · Children'S Hosp Of Philadelphia · U54 · FY2025 · DE
CARE PATH Community Health Worker (CHW) Assessment for Postpartum Health
$1,529,996Pearl McElfish · Univ Of Arkansas For Med Scis · R01 · FY2025 · HD
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
$1,528,567Kathleen E. Rodgers · University Of Arizona · U01 · FY2023 · AG
1/2 IMPRoving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
$1,528,379Manesh R Patel · Duke University · UG3 · FY2023 · HL
COMPREHENSIVE SICKLE CELL CENTER
$1,527,346University Of Southern California · U54 · FY2003 · HL
Genetic & Epidemiologic Predictors of Glucose Homeostasis Measures in Hispanics
$1,527,315Lynne E Wagenknecht · Wake Forest University Health Sciences · R01 · FY2011 · DK
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$1,526,307Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Peripheral and Central Biomarkers of Alzheimer's Disease in Diverse Cohorts
$1,526,245Minerva Maria Carrasquillo · Mayo Clinic Jacksonville · U19 · FY2025 · AG
KIDNEY DISEASE/HYPERTENSION IN AFRICAN AMERICANS--DCC
$1,525,356Cleveland Clinic Foundation · U01 · FY2002 · DK
SPRINT MIND 2020
$1,524,532David M Reboussin · Wake Forest University Health Sciences · R01 · FY2020 · AG
Central Autonomic Control, Aging and Oxidative Stress
$1,524,234Vito John Massari · Howard University · U54 · FY2006 · NS
Craniosynostosis Network
$1,523,621Ethylin Wang Jabs · Icahn School Of Medicine At Mount Sinai · P01 · FY2014 · HD
Approaches To Immunological Intervention In Schistosomiasis
$1,523,013Thomas Wynn · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
ARIC Neurocognitive Study (ARIC-NCS)
$1,522,554David J Couper · Univ Of North Carolina Chapel Hill · U01 · FY2013 · HL
Analytical characterization and validation of blood-biomarkers for monitoring TBI evolution
$1,520,962Ava M. Puccio · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · NS
GENE THERAPY USING VIRAL VECTOR FOR LU AND CARDIOVA
$1,520,543University Of Florida · P50 · FY2000 · HL
Functional GWAS for LVH using iPS-derived Cardiomyocytes: The HyperGEN ciPS Stud
$1,520,512Ulrich Broeckel · Medical College Of Wisconsin · U01 · FY2015 · HL
Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial
$1,520,407Stephen Bradley Freedman · University Of Calgary · R01 · FY2021 · AI
Sex Differences in the Metabolic Syndrome
$1,520,214Karen Reue · University Of California Los Angeles · U54 · FY2022 · DK